Search research articles
Contact Us
Filters
Showing results (41-50 of 74) with videos related to
Page
of 8
Sort By:
Environmental Health Perspectives
|
December 1, 1982
Toxicology of organic drinking water contaminants: trichloromethane, bromodichloromethane, dibromochloromethane and tribromomethane
A E Munson, L E Sain, V M Sanders, et al.
Journal of Medicinal Chemistry
|
December 14, 2011
Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity
Brent D G Page, Haytham Khoury, Rob C Laister, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
|
August 1, 1995
Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia
L M Abbey, G E Kaugars, J C Gunsolley, et al.
Plos One
|
June 22, 2017
Identification of novel small molecules that inhibit STAT3-dependent transcription and function
Iryna Kolosenko, Yasmin Yu, Sander Busker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 25, 2012
Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
Xiaolei Zhang, Peibin Yue, Brent D G Page, et al.
Chembiochem : a European Journal of Chemical Biology
|
August 1, 2009
Disruption of transcriptionally active Stat3 dimers with non-phosphorylated, salicylic acid-based small molecules: potent in vitro and tumor cell activities
Steven Fletcher, Jagdeep Singh, Xiaolei Zhang, et al.
Chemmedchem
|
May 28, 2011
Antagonism of the Stat3-Stat3 protein dimer with salicylic acid based small molecules
Steven Fletcher, Brent D G Page, Xialoei Zhang, et al.
Metallomics : Integrated Biometal Science
|
September 4, 2013
3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents
Maria A Telpoukhovskaia, Cristina Rodríguez-Rodríguez, Jacqueline F Cawthray, et al.
Leukemia & Lymphoma
|
March 9, 2016
STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)-STAT3 pathway
Amy Belton, Lingling Xian, Tait Huso, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 27, 2011
Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain
Brent D G Page, Steven Fletcher, Peibin Yue, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 74) with videos related to
Sort By:
Page
of 8
Environmental Health Perspectives
|
December 1, 1982
Toxicology of organic drinking water contaminants: trichloromethane, bromodichloromethane, dibromochloromethane and tribromomethane
A E Munson, L E Sain, V M Sanders, et al.
Journal of Medicinal Chemistry
|
December 14, 2011
Small molecule STAT5-SH2 domain inhibitors exhibit potent antileukemia activity
Brent D G Page, Haytham Khoury, Rob C Laister, et al.
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
|
August 1, 1995
Intraexaminer and interexaminer reliability in the diagnosis of oral epithelial dysplasia
L M Abbey, G E Kaugars, J C Gunsolley, et al.
Plos One
|
June 22, 2017
Identification of novel small molecules that inhibit STAT3-dependent transcription and function
Iryna Kolosenko, Yasmin Yu, Sander Busker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 25, 2012
Orally bioavailable small-molecule inhibitor of transcription factor Stat3 regresses human breast and lung cancer xenografts
Xiaolei Zhang, Peibin Yue, Brent D G Page, et al.
Chembiochem : a European Journal of Chemical Biology
|
August 1, 2009
Disruption of transcriptionally active Stat3 dimers with non-phosphorylated, salicylic acid-based small molecules: potent in vitro and tumor cell activities
Steven Fletcher, Jagdeep Singh, Xiaolei Zhang, et al.
Chemmedchem
|
May 28, 2011
Antagonism of the Stat3-Stat3 protein dimer with salicylic acid based small molecules
Steven Fletcher, Brent D G Page, Xialoei Zhang, et al.
Metallomics : Integrated Biometal Science
|
September 4, 2013
3-Hydroxy-4-pyridinone derivatives as metal ion and amyloid binding agents
Maria A Telpoukhovskaia, Cristina Rodríguez-Rodríguez, Jacqueline F Cawthray, et al.
Leukemia & Lymphoma
|
March 9, 2016
STAT3 inhibitor has potent antitumor activity in B-lineage acute lymphoblastic leukemia cells overexpressing the high mobility group A1 (HMGA1)-STAT3 pathway
Amy Belton, Lingling Xian, Tait Huso, et al.
Bioorganic & Medicinal Chemistry Letters
|
July 27, 2011
Identification of a non-phosphorylated, cell permeable, small molecule ligand for the Stat3 SH2 domain
Brent D G Page, Steven Fletcher, Peibin Yue, et al.
Page
of 8